To hear about similar clinical trials, please enter your email below
Trial Title:
Radiation Treatment Plan Evaluation Learning Tool Pilot Project
NCT ID:
NCT06115811
Condition:
Radiation Oncology
Conditions: Official terms:
Neoplasms
Conditions: Keywords:
Radiation Oncology
Education
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Other
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
Radiation Treatment Plan Evaluation Learning Tool
Description:
Web-based program comprised of a systematic, oncology treatment plan review system and
learning modules. The case bank of radiation treatments plans is accessible via
econtour.org.
Arm group label:
Radiation Treatment Plan Evaluation Learning Module
Summary:
This study involves both the development of a novel learning tool, the Radiation
Treatment Plan Evaluation Learning Module, as well as a pilot program to validate this
tool as an effective resource to teach treatment plan review and optimization to
radiation oncology residents.
Detailed description:
This study involves both the development of a novel learning tool, the Radiation
Treatment Plan Evaluation Learning Module, as well as a pilot program to validate this
tool as an effective resource to teach treatment plan review and optimization to
radiation oncology residents.
Stud procedures include screening for eligibility and completion of surveys and oncology
examinations.
Participation is expected to last about 6-8 weeks.
It is expected about 20 radiation oncology resident physicians will participate in the
study.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- The pilot program will be open to radiation oncology resident physicians that are in
their PGY-2, PGY-3, or PGY-4 year.
- All residents must have completed a breast cancer-specific radiation oncology
rotation at least 3 months prior to enrollment in the pilot program in order to be
eligible.
Exclusion Criteria:
-The study will not include any special populations.
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Massachusetts General Hospital Cancer Center
Address:
City:
Boston
Zip:
02215
Country:
United States
Contact:
Last name:
Rachel Jimenez, MD
Phone:
617-726-8651
Email:
RBJIMENEZ@PARTNERS.ORG
Start date:
January 15, 2024
Completion date:
September 1, 2025
Lead sponsor:
Agency:
Massachusetts General Hospital
Agency class:
Other
Source:
Massachusetts General Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06115811
